GlassScriptPhysician profile
Harrison A Linder
NPI 1245596139
$1,440.10
in general payments reported to CMS, 2019-2025
17 companies · $171 in 2025
The $171 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $233 · 2021: $159 · 2022: $435 · 2023: $238 · 2024: $64.16 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $473.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $430.75 | 2019-2023 | Senza |
| Boston Scientific Corporation | $234.13 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $166.60 | 2021-2025 | Proclaim, Eterna |
| Stimwave Technologies Incorporated | $152.52 | 2019-2020 | |
| Globus Medical, INC. | $148.73 | 2025 | Senza |
| Pfizer INC. | $45.89 | 2019-2020 | |
| Averitas Pharma INC. | $45.12 | 2023 | Qutenza |
| Ibsa Pharma INC. | $34.86 | 2021-2022 | |
| Si-Bone, INC. | $28.73 | 2019 | |
| Acacia Pharma INC | $24.08 | 2021 | |
| Relievant Medsystems, INC. | $21.64 | 2023 | Intracept |
| Amneal Pharmaceuticals LLC | $20.28 | 2023 | Lyvispah |
| Vertex Pharmaceuticals Incorporated | $19.67 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.55 | 2022 | |
| Electronic Waveform Lab, INC. | $17.53 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $17.52 | 2019 | |
| Avanos Medical | $13.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harrison Linder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.